Treatment strategies for neuroendocrine liver metastases: an update

Introduction: Neuroendocrine liver metastases (NELM) occur in roughly 60–90% of patients with neuroendocrine tumors during the disease course. Understanding the available treatment options for patients presenting with NELM is critical to construct the appropriate therapeutic strategy and achieve the best possible outcomes with regards to symptom control and survival.Areas covered: A review of the literature was conducted regarding the outcomes...